Clinical Trial

Study of Safety and Efficacy of HS-10542 in Patients With Paroxysmal Nocturnal Hemoglobinuria

Name: Study of Safety and Efficacy of HS-10542 in Patients With Paroxysmal Nocturnal Hemoglobinuria — clinical trial record (NCT07470762)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This was a phase 1b/2,open label, multi-center study to assess efficacy and safety of HS-10542 in adulte patients with paroxysmal nocturnal hemoglobinuria (PNH) with signs of active hemolysis.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-03-10.

Trial Details

NCT Number	NCT07470762
Lead Sponsor	Jiangsu Hansoh Pharmaceutical Co., Ltd.
Conditions	Paroxysmal Nocturnal Hemoglobinuria
Enrollment	50 participants
Start Date	2026-02-14
Primary Completion	2027-05-30 (estimated)
Study Completion	2029-07-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-13